Kuno Takayoshi | Division Of Molecular Pharmacology And Pharmacogenomics Kobe University Graduate School Of Medicine

スポンサーリンク

概要

• 同名の論文著者
• Division Of Molecular Pharmacology And Pharmacogenomics Kobe University Graduate School Of Medicineの論文著者

関連著者

• Kuno Takayoshi

  イミュノフロンティア

• Kuno Takayoshi

  Division Of Molecular Pharmacology And Pharmacogenomics Kobe University Graduate School Of Medicine

• Kuno Takayoshi

  神戸大学医学研究科

• Kuno Takayoshi

  Division of Molecular Pharmacology and Pharmacogenomics, Department of Biochemistry and Molecular Bi

• Tamaki Norihiko

  神戸大学医学系研究科

• SHIKU Hiroshi

  Department of Hematology and Oncology, Mie University Graduate School of Medicine

• Kuno Takayoshi

  Division Of Molecular Pharmacology And Pharmacogenomics Department Of Biochemistry And Molecular Bio

• Shiku Hiroshi

  Department Of Cancer Vaccine Mie University Graduate School Of Medicine

• Harada Naozumi

  Basic and Preclinical Research Department ImmunoFrontier, Inc.,

• Hoshiai Kiyotaka

  Pharmacology department, Kobuchisawa Research Laboratories, Fuji Biomedix Co., Ltd.,

• Takahashi Yoshiyasu

  Pharmacology department, Kobuchisawa Research Laboratories, Fuji Biomedix Co., Ltd.,

• Sakaguchi Yasue

  Pharmacology department, Kobuchisawa Research Laboratories, Fuji Biomedix Co., Ltd.,

• Hishida Tadashi

  Manufacturing Process Development Department, ImmunoFrontier, Inc.,

• Hoshiai Kiyotaka

  Pharmacology Department Kobuchisawa Research Laboratories Fuji Biomedix Co. Ltd.

• Harada Naozumi

  Basic And Preclinical Research Department Immunofrontier Inc.

• Hishida Tadashi

  Manufacturing Process Development Department Immunofrontier Inc.

• Sakaguchi Yasue

  Pharmacology Department Kobuchisawa Research Laboratories Fuji Biomedix Co. Ltd.

• Takahashi Yoshiyasu

  Pharmacology Department Kobuchisawa Research Laboratories Fuji Biomedix Co. Ltd.

• Takamoto Takeshi

  神戸大学医学研究科

• Sasaki Masato

  神戸大学医学研究科

• Tamaki Norihiko

  神戸大学医学研究科

もっと見る 閉じる

著作論文

• Preclinical Safety Pharmacology Study of a Novel Protein-Based Cancer Vaccine CHP-NY-ESO-1
• Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged the survival

スポンサーリンク